Affimed N.V. (AFMD)
NASDAQ: AFMD · Real-Time Price · USD
3.350
-0.020 (-0.59%)
Oct 29, 2024, 4:00 PM EDT - Market closed
Affimed Employees
Affimed had 76 employees as of December 31, 2023. The number of employees decreased by 143 or -65.30% compared to the previous year.
Employees
76
Change (1Y)
-143
Growth (1Y)
-65.30%
Revenue / Employee
$104,736
Profits / Employee
-$1,116,384
Market Cap
52.53M
Employees Chart
Related Stocks
Company Name | Employees |
---|---|
Atara Biotherapeutics | 225 |
Champions Oncology | 210 |
Cytosorbents | 186 |
Lucid Diagnostics | 70 |
iCAD, Inc. | 69 |
Aligos Therapeutics | 66 |
OncoCyte | 46 |
LAVA Therapeutics | 37 |
AFMD News
- 7 weeks ago - Affimed to Present at the Cantor Global Healthcare Conference 2024 - GlobeNewsWire
- 7 weeks ago - Affimed N.V. (AFMD) Q2 2024 Earnings Call Transcript - Seeking Alpha
- 7 weeks ago - Affimed Reports Second Quarter 2024 Financial Results & Business Update - GlobeNewsWire
- 7 weeks ago - Affimed Follow Up: Upcoming Acimtamig And AFM24 Updates Could Be Positive Catalysts - Seeking Alpha
- 2 months ago - Affimed Appoints Shawn M. Leland as Chief Executive Officer - GlobeNewsWire
- 2 months ago - Affimed to Report Second Quarter 2024 Financial Results & Corporate Update on September 5, 2024 - GlobeNewsWire
- 4 months ago - Affimed N.V. (AFMD) Q1 2024 Earnings Call Transcript - Seeking Alpha
- 4 months ago - Affimed Reports First Quarter 2024 Financial Results & Business Update - GlobeNewsWire